{
    "doi": "https://doi.org/10.1182/blood.V106.11.5277.5277",
    "article_title": "Cellular Composition of Allogeneic and Autologous PBPC Grafts and Patient Engraftment. ",
    "article_date": "November 16, 2005",
    "session_type": "Abstracts Not Selected for Presentation",
    "abstract_text": "We studied the influence of graft populations on the hematological recovery of PBPC transplants. The data shown is a retrospective study of 36 patients (median age 41, range 16\u201367) who underwent allogeneic transplant from HLA-matched siblings and 29 patients (median age 25, range 20\u201368) who underwent autologous PBPC transplants between June 2002 and July 2005. The cell populations studied were: total nucleated cells (TNC), CD34+ cells, T cells (CD3+) and NK cells (CD3\u2212/CD56+). The hematological engraftment was evaluated by the following parameters: time to absolute neutrophil count (ANC)>0.5x109/L, platelets>20x109/L, absolute lymphocyte count (ALC)>0.5x109/L and ALC at day +15. The median cell doses infused in patients are summarised in Table 1 Table 1- PBPC cell population infused per Kg of patient body weight  . TNC x 108 . CD34+ cells x 106 . T cells x 108 . NK cells x 106 . *median **range Allogeneic 12.8 * 7.5 3.2 36.8  3.6 \u2013 30.7 ** 3.4 \u2013 10.5 0.7 \u2013 9.8 4.2 \u2013 136.6 Autologous 12 3.26 3.5 29  4.1\u2013 51.0 2.2 \u2013 7.0 0.1\u2013 0.4 7.4 \u2013 351 . TNC x 108 . CD34+ cells x 106 . T cells x 108 . NK cells x 106 . *median **range Allogeneic 12.8 * 7.5 3.2 36.8  3.6 \u2013 30.7 ** 3.4 \u2013 10.5 0.7 \u2013 9.8 4.2 \u2013 136.6 Autologous 12 3.26 3.5 29  4.1\u2013 51.0 2.2 \u2013 7.0 0.1\u2013 0.4 7.4 \u2013 351 View Large Spearman correlation analysis showed for the allogeneic PBPC grafts, correlation between TNC and NK cells collected (p=0.002), whereas for the autologous grafts there was correlation between TNC and NK cells (p=0.000) and CD34+ cells (p=0.004) collected. To asses the importance of cell dose infused in the hematologic engraftment of the two patient groups, neutrophil, platelet and lymphocyte recovery was determined (Table 2). Table 2- Patient engraftment  . Day to ANC>0.5x109/L . Day to platelets>0.2x109/L . Day to ALC>0.5x109/L . ALC day +15 cell/\u03bcl . *median **range Allogeneic 11 * 12 11 715  8 \u2013 15 ** 8 \u2013 29 2 \u2013 14 190 \u2013 4670 Autologous 11 11 12 1178  7 \u2013 13 8 \u2013 18 10 \u2013 21 230 \u2013 4410 . Day to ANC>0.5x109/L . Day to platelets>0.2x109/L . Day to ALC>0.5x109/L . ALC day +15 cell/\u03bcl . *median **range Allogeneic 11 * 12 11 715  8 \u2013 15 ** 8 \u2013 29 2 \u2013 14 190 \u2013 4670 Autologous 11 11 12 1178  7 \u2013 13 8 \u2013 18 10 \u2013 21 230 \u2013 4410 View Large For both groups of patients, engraftment occurred within the expected time and ALC day +15 cell/\u03bcl was different (median 715 cell/\u03bcl and 1178 cell/\u03bcl for allogeneic and autotransplanted patients respectively). For the allogeneic transplanted patients, Spearman correlation analysis showed that the dose of NK cells infused was significantly correlated with ALC at day +15 (p=0.021). There was also correlation between the time to platelets and ANC engraftment (p=0.008) and time to platelets engraftment and ALC at day +15 (p=0.046). For the autologous patients there was no correlation between cell populations of the grafts and the hematologic engraftment. Our data provide evidence that in allogeneic transplants the NK dose influences early ALC recovery. However, it is important to continue this study to balance the importance of cell population doses both in allogeneic and autologous transplants.",
    "topics": [
        "engraftment",
        "tissue transplants",
        "human leukocyte antigens",
        "transplantation",
        "absolute neutrophil count",
        "lymphocyte count measurement",
        "natural killer cells",
        "blood platelets",
        "correlation studies",
        "t-lymphocytes"
    ],
    "author_names": [
        "Isabel L. Barbosa, PhD",
        "Patricia A. Benevides, BSc",
        "Claudia C. Sousa, BSc",
        "Sergio B. Machado Lopes, BSc",
        "Ana R. Tavares, BSc",
        "Fernando Campilho, MD",
        "Antonio Campos, MD",
        "Carlos P. Vaz, MD",
        "Susana R. Sousa, MD",
        "Pedro Pimentel, MD",
        "Alzira Carvalhais, MD"
    ],
    "author_dict_list": [
        {
            "author_name": "Isabel L. Barbosa, PhD",
            "author_affiliations": [
                "Imuno-Hemoterapia, Instituto Portugue\u0302s de Oncologia Porto SA, Porto, Portugal",
                " "
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Patricia A. Benevides, BSc",
            "author_affiliations": [
                "Imuno-Hemoterapia, Instituto Portugue\u0302s de Oncologia Porto SA, Porto, Portugal",
                " "
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Claudia C. Sousa, BSc",
            "author_affiliations": [
                "Imuno-Hemoterapia, Instituto Portugue\u0302s de Oncologia Porto SA, Porto, Portugal",
                " "
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Sergio B. Machado Lopes, BSc",
            "author_affiliations": [
                "Imuno-Hemoterapia, Instituto Portugue\u0302s de Oncologia Porto SA, Porto, Portugal",
                " "
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Ana R. Tavares, BSc",
            "author_affiliations": [
                "Imuno-Hemoterapia, Instituto Portugue\u0302s de Oncologia Porto SA, Porto, Portugal",
                " "
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Fernando Campilho, MD",
            "author_affiliations": [
                "Servic\u0327o de Transplantac\u0327a\u0303o de Medula O\u0301ssea, Instituto Portugue\u0302s de Oncologia Porto SA, Porto, Portugal",
                " "
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Antonio Campos, MD",
            "author_affiliations": [
                "Servic\u0327o de Transplantac\u0327a\u0303o de Medula O\u0301ssea, Instituto Portugue\u0302s de Oncologia Porto SA, Porto, Portugal",
                " "
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Carlos P. Vaz, MD",
            "author_affiliations": [
                "Servic\u0327o de Transplantac\u0327a\u0303o de Medula O\u0301ssea, Instituto Portugue\u0302s de Oncologia Porto SA, Porto, Portugal",
                " "
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Susana R. Sousa, MD",
            "author_affiliations": [
                "Imuno-Hemoterapia, Instituto Portugue\u0302s de Oncologia Porto SA, Porto, Portugal",
                " "
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Pedro Pimentel, MD",
            "author_affiliations": [
                "Servic\u0327o de Transplantac\u0327a\u0303o de Medula O\u0301ssea, Instituto Portugue\u0302s de Oncologia Porto SA, Porto, Portugal",
                " "
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Alzira Carvalhais, MD",
            "author_affiliations": [
                "Imuno-Hemoterapia, Instituto Portugue\u0302s de Oncologia Porto SA, Porto, Portugal",
                " "
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-04-26T15:32:59",
    "is_scraped": "1"
}